meet Cologuard

If you are 50 and older and at average risk for colon cancer, Cologuard is a noninvasive screening option that is available by prescription only and may be right for you.

If you are 50 and older and at average risk for colon cancer, Cologuard is a noninvasive screening option that is available by prescription only and may be right for you.

Easy to use

You can use Cologuard right at home! There is no special prep or need for time off. Plus, you don’t have to make any changes to your diet or medication.

Read more

Cologuard is 92% Effective

Effective

As the only FDA-approved test based on stool DNA science, Cologuard finds 92% of colon cancers and 69% of the highest-risk precancers with 87% specificity.

Read more

Cologuard is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. A positive result may indicate the presence of colorectal cancer (CRC) or advanced adenoma (AA) and should be followed by diagnostic colonoscopy. Cologuard is indicated to screen adults of either sex, 50 years or older, who are at typical average-risk for CRC. Cologuard is not a replacement for diagnostic colonoscopy or surveillance colonoscopy in high risk individuals.

Cologuard is not for high risk individuals, including those with a history of colorectal cancer and advanced adenoma, a family history of colorectal cancer, IBD or certain hereditary syndromes. Positive Cologuard results should be referred to diagnostic colonoscopy. A negative Cologuard test result does not guarantee absence of cancer or advanced adenoma. Following a negative result, patients should continue participating in a screening program at an interval and with a method appropriate for the individual patient. Cologuard performance when used for repeat testing has not been evaluated or established. Rx only.

Carousel with helpful links. Navigation buttons disabled for a screen reader user.